Question 1

What is PharmAla Biotech Holdings?

Accepted Answer

PharmAla Biotech Holdings is a Company.

Question 2

How often does PharmAla Biotech Holdings appear in global news?

Accepted Answer

Tracked across 1 news events drawn from 7 articles.

Question 3

When was PharmAla Biotech Holdings first tracked by Ergen?

Accepted Answer

First tracked on Jul 06, 2026.

Question 4

When was PharmAla Biotech Holdings last mentioned in news?

Accepted Answer

Last active on Jul 06, 2026.

Question 5

What is PharmAla Biotech Holdings's current news sentiment?

Accepted Answer

Aggregate sentiment score: 75 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is PharmAla Biotech Holdings in global news coverage?

Accepted Answer

Attention score of 4, derived from article volume and coverage intensity across 1 events.

Question 7

What is the most recent event involving PharmAla Biotech Holdings?

Accepted Answer

PharmAla ALA-002 Manufacturing, Patent, Australia (Jul 06, 2026, 7 articles).

Question 8

How did the "PharmAla ALA-002 Manufacturing, Patent, Australia" event impact PharmAla Biotech Holdings?

Accepted Answer

PharmAla Biotech Holdings successfully completed GMP manufacturing of drug substance for Non-racemic MDMA, was granted an Australian patent for Non-racemic MDMA, and will brand Non-racemic MDMA as LaNeo Gen 2 in Australia. These advancements position the company for upcoming clinical activities and commercialization.

Question 9

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.